Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Iterum Therapeutics Plc (ITRM)

0.9   0.01 (1.12%) 08-13 15:54
Open: 0.88 Pre. Close: 0.89
High: 0.918 Low: 0.8751
Volume: 326,384 Market Cap: 19M
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The company is developing sulopenem, a novel penem anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. Iterum Therapeutics plc was founded in 2015 and is headquartered in Dublin, Ireland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.922 - 0.928 0.928 - 0.934
Low: 0.865 - 0.873 0.873 - 0.88
Close: 0.888 - 0.9 0.9 - 0.911

Technical analysis

as of: 2020-08-13 4:35:31 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.26     One year: 1.42
Support: Support1: 0.85    Support2: 0.71
Resistance: Resistance1: 1.08    Resistance2: 1.22
Pivot: 1.03
Moving Average: MA(5): 0.96     MA(20): 1.06
MA(100): 2.16     MA(250): 3.09
MACD: MACD(12,26): -0.12     Signal(9): -0.13
Stochastic oscillator: %K(14,3): 12.72     %D(3): 14.12
RSI: RSI(14): 28.20
52-week: High: 7.24  Low: 0.85  Change(%): -86.7
Average Vol(K): 3-Month: 135541  10-Days: 36110

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ITRM has closed above bottom band by 0.1%. Bollinger Bands are 79.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to ITRM's normal range. The bands have been in this narrow range for 38 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 11 Aug 2020
Iterum Therapeutics Commences Rights Offering Nasdaq:ITRM - GlobeNewswire

Mon, 10 Aug 2020
Iterum Therapeutics (ITRM) Receives a Hold from H.C. Wainwright - Smarter Analyst

Thu, 06 Aug 2020
Iterum Therapeutics Reports Second Quarter 2020 Financial Results - GlobeNewswire

Mon, 03 Aug 2020
Iterum Therapeutics plc (NASDAQ: ITRM) 52-Week High Located At $7.65, Forget The Dips, Just Ride The Rips - The Comet Reports

Wed, 22 Jul 2020
Iterum Therapeutics plc (ITRM) Sitting On The Launchpad, Waiting For The Long Term Buyers - Stocks Register

Wed, 22 Jul 2020
Iterum Therapeutics plc (NASDAQ:ITRM) share price rebounds 24.59% from the lows – but can it keep going? - Marketing Sentinel

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 18
Shares Float (M) 10
% Held by Insiders 3.58
% Held by Institutions 70.07
Shares Short (K) 385
Shares Short P. Month (K) 449

Stock Financials

EPS -6.728
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -2.810
Profit Margin
Operating Margin
Return on Assets (ttm) -89.8
Return on Equity (ttm) -1995.2
Qtrly Rev. Growth
Gross Profit (p.s.) 0.002
Sales Per Share
EBITDA (p.s.) -5.282
Qtrly Earnings Growth
Operating Cash Flow (M) -91
Levered Free Cash Flow (M) -29

Stock Valuations

PE Ratio -0.13
PEG Ratio
Price to Book value -0.32
Price to Sales
Price to Cash Flow -0.18

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.